Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Ravoxertinib |
| Trade Name | |
| Synonyms | GDC-0994 |
| Drug Descriptions |
Ravoxertinib (GDC-0994) is a small molecule inhibitor of ERK1 and ERK2, which may decrease tumor growth (Cancer Res October 1, 2014 74:DDT02-03, PMID: 32311798, PMID: 31848189). |
| DrugClasses | ERK Inhibitor (pan) 21 |
| CAS Registry Number | 1453848-26-4 |
| NCIT ID | C107241 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cobimetinib + Ravoxertinib | Cobimetinib Ravoxertinib | 0 | 0 |
| Ravoxertinib | Ravoxertinib | 11 | 2 |
| Ravoxertinib + Vemurafenib | Ravoxertinib Vemurafenib | 1 | 0 |